Leo Goodwin Institute for Cancer Research, Inc. v. United States

521 F.2d 801, 63 C.C.P.A. 114, 1975 CCPA LEXIS 131
CourtCourt of Customs and Patent Appeals
DecidedSeptember 4, 1975
DocketCommerce Appeal No. 4
StatusPublished
Cited by2 cases

This text of 521 F.2d 801 (Leo Goodwin Institute for Cancer Research, Inc. v. United States) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Leo Goodwin Institute for Cancer Research, Inc. v. United States, 521 F.2d 801, 63 C.C.P.A. 114, 1975 CCPA LEXIS 131 (ccpa 1975).

Opinions

Almond, Senior Judge.

The Leo Goodwin Institute for Cancer Research, Inc. (appellant) appeals from a decision of the Secretary of Commerce1 denying its application for duty-free entry of an electron microscope pursuant to item 851.60, Tariff Schedules of the United States2 under section 6 of the Educational, Scientific and Cultural Materials Importation Act of 1966.3 The basis for the denial was the finding that “[a]n instrument or apparatus of equivalent scientific value to the foreign article, for such purposes as this article is intended to be used, is being manufactured in the United States.” We affirm.

Appellant filed its first application for duty-free entry of a previously ordered electron microscope on October 2, 1972.4 The microscope, a

[116]*116Philips EM-201, manufactured in Holland by Philips Electronics Instruments Company, was to be used in connection with investigations to be conducted on the nature of malignant diseases, as well as to train graduate and post-graduate students. The application asserted:

[T]here is no electron microscope currently manufactured in the United States which is capable of performing the same function as the Philips 201 instrument. * * * RCA no longer manufactures electron microscopes, and it is our understanding that * * * the Forgflo Corporation purchased the RCA designs, manufactured one or two instruments, but that these are no longer on the market.

Describing appellant’s efforts to ascertain the availability of a domestic instrument or apparatus of equivalent scientific value to the foreign articles, the application continued:

We have contacted Forgflo Corporation by telephone regarding the availability of an instrument and the delivery time and were informed that although the company intended to resume production of their electron microscope, neither a cost, delivery date or adequate description were available at this time. Based on information from American experts in the field of electron microscopy, the Forgflo Corporation is on the verge of bankruptcy and can be disregarded as a factor in the manufacture of electron optics.

A notice of the application was published in the Federal Register5 as required by the statute, and a letter, dated February 14, 1973, was thereafter received from Forgflo’s chief engineer in the electron microscope division, which provided in pertinent part:

I wish to assure you that Forgflo Corporation is currently engaged in the manufacture and sale of the EMU4 Series Transmission Electron Microscope and that we have been so engaged, on a continuous and uninterrupted basis, since July of 1969.

Evidencing its continued operations, Forgflo also submitted literature describing its EMU-4 electron microscope and copies of correspondence with potential customers bearing dates ranging from January 26, 1972 to January 9, 1973.

On March 30, 1973, after reviewing the application, the National Institute of Health’s Florence Agreement Committee, acting under delegation from the Secretary of Health, Education and Welfare, recommended that it be denied without prejudice to its resubmission because “[t]he description of the research or teaching is not given in adequate detail to establish pertinent characteristics for the article.” The Committee further commented that “[t]he domestic EMU-4C was being offered for sale when the article was ordered. The application does not clearly show this instrument to be inadequate for the research work or the teaching described.” On April 11, 1973, appellant’s application was denied without prejudice.

A second application for the same article was submitted on July 9, 1973. The application asserted, inter alia, “[t]he overriding considera[117]*117tion for the Philips EM-201 is its relative simplicity of design and ease of operation on a daily basis.” The application further stated:

We have been informed that the company (Forgflo Corporation) is bankrupt but that the RCA Corporation will continue to service their instruments on a parts-available basis. Inasmuch as there are several Philips instruments in South Florida, prompt and economic service is available in comparison to servicing of the RCA EMU-4C.

Notification of the second application was thereafter published in the Federal Register,6 and the Florence Agreement Committee, again citing an insufficient description, recommended denial without prejudice. The Committee also noted, as it had previously, that domestic instruments, including the EMU-4C, had not been shown to be scientifically inadequate for the intended purpose. This second application was denied without prejudice on November 16, 1973.

A third and final application was filed on February 20, 1974, reciting ten factors, shown below in tabular form as they appear in the application, which were asserted to be necessary for the intended uses of the Philips instrument and which were further alleged to be lacking in the domestically manufactured unit.

[118]

Free access — add to your briefcase to read the full text and ask questions with AI

Related

University of Miami v. United States
559 F.2d 23 (Customs and Patent Appeals, 1977)

Cite This Page — Counsel Stack

Bluebook (online)
521 F.2d 801, 63 C.C.P.A. 114, 1975 CCPA LEXIS 131, Counsel Stack Legal Research, https://law.counselstack.com/opinion/leo-goodwin-institute-for-cancer-research-inc-v-united-states-ccpa-1975.